Selin Gencer, Yvonne Döring, Yvonne Jansen, Soyolmaa Bayasgalan, Yi Yan, Mariaelvy Bianchini, Ismail Cimen, Madeleine Müller, Linsey J F Peters, Remco T A Megens, Philipp von Hundelshausen, Johan Duchene, Patricia Lemnitzer, Oliver Soehnlein, Christian Weber, Emiel P C van der Vorst
Atherosclerosis is the foundation of potentially fatal cardiovascular diseases and it is characterized by plaque formation in large arteries. Current treatments aimed at reducing atherosclerotic risk factors still allow room for a large residual risk; therefore, novel therapeutic candidates targeting inflammation are needed. The endothelium is the starting point of vascular inflammation underlying atherosclerosis and we could previously demonstrate that the chemokine axis CXCL12-CXCR4 plays an important role in disease development...
June 8, 2022: Basic Research in Cardiology